When the biggest retailer in the country says employers should be required to contribute to their employees’ health-care costs, even as business groups are pushing hard against such an idea, there’s sure to be a fight. So, two weeks after... 

  Stem cell research invokes extreme reaction in different people. Due to its vast scope and immense benefits, scientists are relentlessly pursuing legalizing the research and to include as many areas as possible. One of the controversial areas is the... 

Sen. Chuck Grassley has a record of hammering nonprofit hospitals about whether they’re restricting care based on patients’ ability to pay and about how much care they provide for the uninsured in relation to the tax exemptions they enjoy.... 

The day-in, day-out coverage of the Washington health-reform debate has taken on the feel of campaign coverage, with daily stories converging on a theme. This morning, for example, we find a raft of articles suggesting that the effort is stalling amid... 

Two weeks ago, the drug industry agreed to reduce Medicare drug costs , forgoing $80 billion in revenue over 10 years, as part of the health-care overhaul. The move was thought to be a trade-off against potentially more severe cuts. Now, the hospital... 

The agency that runs Medicare today suggested making an obscure accounting change that could make it easier for Congress to change how Medicare pays doctors. The issue goes back to a law passed in the 1990s that was supposed to ensure that the amount... 

Swimming against the corporate tide, Wal-Mart yesterday sent an open letter to President Obama supporting a federal mandate that would require most employers to contribute to their workers’ health-insurance coverage. Here’s the letter that... 

A bit of Washington health-reform action from one of yesterday’s Sunday morning news shows. Chuck Grassley and David Axelrod both talked health care on ABC’s This Week. Grassley plumped for the idea of taxing high-end health benefits. Axelrod... 

President Obama still supports having a government-backed health-insurance plan compete against private insurers. But if Congress passes a bill without a public plan, he might sign it. He discussed the subject at some length at yesterday’s press... 

Ending settlements in which branded drug makers pay generic ones to delay entry into the market, known as “pay-for-delay” settlements, would save consumers $3.5 billion a year , plus “significant savings” for the federal government,...